Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]

Bulletin du cancer - 1 Jan 2000

Troussard Xavier, Maitre Elsa, Paillassa Jérôme

Abstract excerpt

Hairy cell leukemia is a rare form of leukemia: three hundred new cases are diagnosed each year in France. The diagnosis is based on: (1) morphological examination of the blood and bone marrow smear, (2) analysis by flow cytometry of hairy cells, which express three or the four following markers: CD11c, CD25, CD103 and CD123, (3) identification of the BRAFV600E mutation, a true molecular marker of the disease....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Antineoplastic Agents, Immunological
Share to Bacterial Toxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exotoxins

Share to Leukemia, Hairy Cell

Share to Neoplasms, Second Primary

Share to Rare Diseases

Share to Rituximab

Source

Identifiers

PMID: 34023063
DOI: 10.1016/j.bulcan.2021.03.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]PMID 34023063Read ↗

Biology and Treatment of Hairy Cell Leukemia.Semantic proximity Read ↗

Hairy cell leukemia (HCL) and HCL-like disorders: present, emergent treatment options and future directions.Semantic proximity Read ↗

[Novelties in the diagnostics and therapy of hairy cell leukemia].Semantic proximity Read ↗

Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach.Semantic proximity Read ↗

[Molecular and therapeutic advances in Hairy cell leukemia].Semantic proximity Read ↗

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.Semantic proximity Read ↗

Hairy cell leukemia: update and current therapeutic approach.Semantic proximity Read ↗

Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.Semantic proximity Read ↗

New insights in the management of patients with hairy cell leukemia.Semantic proximity Read ↗

Update on the biology and treatment options for hairy cell leukemia.Semantic proximity Read ↗

Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.Semantic proximity Read ↗

Historical overview of hairy cell leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.